Skip to main
MMNFQ
MMNFQ logo

MedMen Enterprises Inc (MMNFQ)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy MMNFQ Stock

About MedMen Enterprises Inc (MMNFQ)

MedMen Enterprises, Inc. engages in the manufacture and marketing of cannabis products. It operates through the following geographical segments: California, Illinois, Nevada, Arizona, and Massachusetts. The company was founded by Adam Bierman and Andrew Modlin on May 21, 1987 and is headquartered in Boca Raton, FL.
Market cap
Today's volume
Revenue (TTM)
Avg. daily volume61.27K
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)-0.53x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

The 52-week high for MMNFQ stock is $0.01. The current MMNFQ stock price $undefined is 100.00% below its 52-week high

No, the MMNFQ stock does not pay dividends to its shareholders

How to buy MMNFQ stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MMNFQ stock

    Navigate to the Explore page. Then, type MMNFQ into the search bar. When you see MMNFQ stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MMNFQ stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy MMNFQ Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.